Repligen Corporation (RGEN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Repligen Corporation (RGEN) has a cash flow conversion efficiency ratio of 0.016x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($32.77 Million) by net assets ($2.11 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Repligen Corporation worth for the company's overall valuation and market capitalisation.
Repligen Corporation - Cash Flow Conversion Efficiency Trend (1990–2025)
This chart illustrates how Repligen Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Repligen Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Repligen Corporation ranked by their cash flow conversion efficiency. Explore RGEN cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bentley Systems Inc
NASDAQ:BSY
|
0.158x |
|
Chart Industries Inc
NYSE:GTLS
|
0.035x |
|
Masimo Corporation
NASDAQ:MASI
|
0.084x |
|
FirstCash Inc
NASDAQ:FCFS
|
0.076x |
|
Kymera Therapeutics Inc
NASDAQ:KYMR
|
-0.036x |
|
Abivax SA American Depositary Shares
NASDAQ:ABVX
|
-0.118x |
|
Hotai Motor Co Ltd
TW:2207
|
0.112x |
|
Chandra Asri Petrochemical Tbk
JK:TPIA
|
0.058x |
Annual Cash Flow Conversion Efficiency for Repligen Corporation (1990–2025)
The table below shows the annual cash flow conversion efficiency of Repligen Corporation from 1990 to 2025. View Repligen Corporation share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.11 Billion | $117.42 Million | 0.056x | -37.30% |
| 2024-12-31 | $1.97 Billion | $175.39 Million | 0.089x | +53.85% |
| 2023-12-31 | $1.97 Billion | $113.92 Million | 0.058x | -35.83% |
| 2022-12-31 | $1.91 Billion | $172.08 Million | 0.090x | +32.43% |
| 2021-12-31 | $1.75 Billion | $119.02 Million | 0.068x | +66.06% |
| 2020-12-31 | $1.53 Billion | $62.62 Million | 0.041x | -35.43% |
| 2019-12-31 | $1.06 Billion | $67.22 Million | 0.063x | +103.79% |
| 2018-12-31 | $-19.60 Million | $32.77 Million | -1.672x | -201.82% |
| 2017-12-31 | $-31.51 Million | $17.45 Million | -0.554x | -1342.81% |
| 2016-12-31 | $168.76 Million | $7.52 Million | 0.045x | -63.66% |
| 2015-12-31 | $122.75 Million | $15.05 Million | 0.123x | +154.64% |
| 2014-12-31 | $-81.99 Million | $18.40 Million | -0.224x | -189.92% |
| 2013-12-31 | $103.89 Million | $25.93 Million | 0.250x | +56.24% |
| 2012-12-31 | $84.12 Million | $13.44 Million | 0.160x | +356.45% |
| 2011-12-31 | $66.00 Million | $2.31 Million | 0.035x | -27.35% |
| 2010-12-31 | $67.09 Million | $3.23 Million | 0.048x | +230.28% |
| 2009-12-31 | $66.21 Million | $-2.45 Million | -0.037x | -140.13% |
| 2008-12-31 | $68.46 Million | $6.31 Million | 0.092x | -84.62% |
| 2007-12-31 | $64.21 Million | $38.47 Million | 0.599x | +3496.62% |
| 2006-12-31 | $24.34 Million | $405.48K | 0.017x | +0.50% |
| 2005-12-31 | $25.06 Million | $415.38K | 0.017x | +150.94% |
| 2004-12-31 | $24.44 Million | $-795.28K | -0.033x | +85.04% |
| 2003-12-31 | $26.30 Million | $-5.72 Million | -0.217x | -25.49% |
| 2002-12-31 | $30.34 Million | $-5.26 Million | -0.173x | +2.07% |
| 2001-12-31 | $26.87 Million | $-4.75 Million | -0.177x | -12.91% |
| 2000-12-31 | $29.48 Million | $-4.62 Million | -0.157x | -75.15% |
| 1999-12-31 | $35.03 Million | $-3.13 Million | -0.089x | +70.15% |
| 1998-12-31 | $4.00 Million | $-1.20 Million | -0.300x | -126.98% |
| 1997-12-31 | $5.30 Million | $-700.00K | -0.132x | +73.58% |
| 1996-12-31 | $6.40 Million | $-3.20 Million | -0.500x | +73.66% |
| 1995-12-31 | $4.90 Million | $-9.30 Million | -1.898x | -102.80% |
| 1994-12-31 | $15.60 Million | $-14.60 Million | -0.936x | -7.18% |
| 1993-12-31 | $28.40 Million | $-24.80 Million | -0.873x | -1517.79% |
| 1992-12-31 | $35.20 Million | $-1.90 Million | -0.054x | +67.61% |
| 1991-12-31 | $51.60 Million | $-8.60 Million | -0.167x | -50.29% |
| 1990-12-31 | $51.40 Million | $-5.70 Million | -0.111x | -- |
About Repligen Corporation
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, … Read more